Related references
Note: Only part of the references are listed.Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
Abigail S. Caudle et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Taxanes as primary chemotherapy for early breast cancer -: Meta-analysis of randomized trials
Federica Cuppone et al.
CANCER (2008)
Chronological changing patterns of clinical characteristics of Korean breast cancer patients during 10 years (1996-2006) using nationwide breast cancer registration on-line program: Biannual update
Seung Sang Ko
JOURNAL OF SURGICAL ONCOLOGY (2008)
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
Keun Seok Lee et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27
HD Bear et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
V Guarneri et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy
L Gianni et al.
CLINICAL CANCER RESEARCH (2005)
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
R Rouzier et al.
CLINICAL CANCER RESEARCH (2005)
Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer:: The GEPARDUO Study of the German Breast Group
G von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes
M Cristofanilli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study
G von Minckwitz et al.
ANNALS OF ONCOLOGY (2005)
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
MC Mathieu et al.
EUROPEAN JOURNAL OF CANCER (2004)
Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
AE Ring et al.
BRITISH JOURNAL OF CANCER (2004)
Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma
VF Cocquyt et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
